Cytosorbents (CTSO) FCF Margin (2011 - 2026)
Cytosorbents (CTSO) reported FCF Margin of 13.23% for Q1 2026, up 2651.0% on a YoY basis from 0.48% in Q1 2025, and up 75.23% quarter-over-quarter from 53.42% in Q4 2025.
Cytosorbents (CTSO) FCF Margin (2011 - 2026) Analysis & Trends
Cytosorbents has reported FCF Margin for 16 years, with the latest figure at 13.23% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2651.0% year-over-year to 13.23%; the trailing twelve-month figure through Mar 2026 stood at 27.54% (up 1011.0% YoY), and the FY2025 full-year result was 33.84%, up 749.0% from the prior year.
- FCF Margin for Q1 2026 stood at 13.23%, up from 53.42% in the prior quarter.
- The five-year high for FCF Margin was 13.23% in Q1 2026, with the low at 131.11% in Q2 2022.
- Historically, FCF Margin has averaged 55.9% across 5 years, with a median of 53.42% in 2025.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 10762 bps — and 2023, when it soared 8509 bps.
- Cytosorbents' FCF Margin stood at 118.71% in 2022, then jumped by 37 bps to 75.02% in 2023, then soared by 65 bps to 26.34% in 2024, then slumped by 103 bps to 53.42% in 2025, then surged by 75 bps to 13.23% in 2026.
- The last three FCF Margin figures came in at 13.23% (Q1 2026), 53.42% (Q4 2025), and 27.35% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -1.28% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 3.98% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 37.67% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 15.44% |
| 10 | Cytosorbents | 25.72 Mn | 20.92 Mn | 6.13 Mn | -13.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.23% |
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | -27.35% |
| Jun 30, 2025 | -16.08% |
| Mar 31, 2025 | -39.74% |
| Dec 31, 2024 | -26.34% |
| Sep 30, 2024 | -30.36% |
| Jun 30, 2024 | -54.42% |
| Mar 31, 2024 | -54.23% |
| Dec 31, 2023 | -75.02% |
| Sep 30, 2023 | -60.71% |
| Jun 30, 2023 | -76.78% |
| Mar 31, 2023 | -32.89% |
| Dec 31, 2022 | -118.71% |
| Sep 30, 2022 | -21.96% |
| Jun 30, 2022 | -131.11% |
| Mar 31, 2022 | -117.99% |
| Dec 31, 2021 | -84.70% |
| Sep 30, 2021 | -29.88% |
| Jun 30, 2021 | -23.49% |